临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00225173 | Hodgkin Disease | Phase 2 | Terminated | - | United States, California ... 展开 >> Stanford University Medical Center Stanford, California, United States, 94305 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.86mL 0.57mL 0.29mL |
14.32mL 2.86mL 1.43mL |
28.63mL 5.73mL 2.86mL |